Jounce Therapeutics, Inc.

Historical 13F Holders

Symbol
JNCE
CUSIP
481116101
All holders as of
Q2 2023
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2023 Q2 1 670 k $918 k
2023 Q1 90 34.6 M $64.2 M
2022 Q4 91 36.7 M $40.7 M
2022 Q3 106 42.6 M $99.8 M
2022 Q2 104 42.7 M $129 M
2022 Q1 118 42.3 M $287 M
2021 Q4 129 41.8 M $349 M
2021 Q3 119 36.4 M $271 M
2021 Q2 137 36.0 M $245 M
2021 Q1 131 36.8 M $378 M
2020 Q4 116 28.9 M $202 M
2020 Q3 111 25.4 M $207 M
2020 Q2 98 26.1 M $180 M
2020 Q1 97 26.5 M $126 M
2019 Q4 108 25.6 M $223 M
2019 Q3 80 24.2 M $80.7 M
2019 Q2 90 24.6 M $122 M
2019 Q1 82 25.3 M $157 M
2018 Q4 86 24.4 M $82.3 M
2018 Q3 92 27.2 M $177 M
2018 Q2 88 27.5 M $211 M
2018 Q1 101 30.0 M $670 M
2017 Q4 84 29.2 M $373 M
2017 Q3 76 15.3 M $239 M
2017 Q2 72 14.0 M $195 M
2017 Q1 60 12.7 M $270 M